companydata.dkZYMENEX ApS: Financial statements 2013
CVR: 27394752
ZYMENEX ApS (CVR 27394752) has filed annual accounts for 2013. In 2013, the company reported a net result of DKK -33,757,937 compared with DKK -42,037,858 the year before. Equity amounted to DKK -65,821,766.
- Profit/Loss
- -33,757,937 kr.
- Equity
- -65,821,766 kr.
- Total Assets
- 5,100,323 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | - | -33.8 mio. | -65.8 mio. | - |
| 2012 | - | - | -42 mio. | -32.1 mio. | - |
Find more companies like ZYMENEX ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2013
As of August 23, 2013, EY Godkendt Revisionspartnerselskab has been appointed auditor of ZYMENEX ApS.
As of August 23, 2013, Beierholm Godkendt Revisionspartnerselskab has stepped down as auditor of ZYMENEX ApS.
As of August 23, 2013, Paolo Patri has joined the board of directors of ZYMENEX ApS.
As of August 23, 2013, Per Toft Valstorp has left the board of directors of ZYMENEX ApS.
As of August 23, 2013, Bo Jesper Hansen has left the board of directors of ZYMENEX ApS.
As of August 23, 2013, Andrew Philip Dickinson is registered as chairman of ZYMENEX ApS.
As of August 23, 2013, Sten Verland has stepped down as chairman of ZYMENEX ApS.
ZYMENEX ApS has published its annual report for 2012. The net result was DKK -42,037,858.
About ZYMENEX ApS
ZYMENEX ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2003 and dissolved in 2019. The company was registered under the industry Forskning og eksperimentel udvikling indenfor bioteknologi. The company has 1 employee. In 2018, the company reported revenue of DKK 10,758,000 and a net result of DKK 1,292,000 compared with DKK 3,404,000 the year before. Equity amounted to DKK 82,550,000.